Inactive Instrument

Highlights Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y2081

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Top Midday Decliners	15/05	MT
Aethlon Medical, Inc. Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma	10/05	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	15/02	CI
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	15/11	CI
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology	10/23/10	CI
Reverse Split: 1 of 10	05/23/05	FA
Aethlon Medical Board Approves 1-for-10 Reverse Stock Split	04/23/04	MT
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Aethlon Medical Taps Namsa to Manage Planned Clinical Trial of Medical Device for Cancer	30/23/30	MT
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	15/22/15	CI
Aethlon Medical, Inc. Announces Early Feasibility Study of the Hemopurifier	30/22/30	CI
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	10/22/10	CI
Aethlon Medical, Inc. Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment	11/22/11	CI
Aethlon Medical Posts Wider Loss, Lower Revenue for Full-Year Fiscal 2022	29/22/29	MT
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	29/22/29	CI
Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants	02/22/02	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	15/22/15	CI
Aethlon Medical Pares Fiscal Q3 Loss per Share as Revenue Plunges	15/22/15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y2081

Highlights

Filters